Market Cap N/A
Revenue (ttm) 390.40M
Net Income (ttm) -11.93M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin -3.06%
Debt to Equity Ratio N/A
Volume 2,821,941
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founde...

Industry: Health Information Services
Sector: Healthcare
Phone: 415 726 2206
Address:
455 Market Street, Suite 700, San Francisco, United States
victorgn
victorgn Jun. 24 at 7:01 PM
Rank Ticker Entry Quality Upside Risk Level Best For 1 $APP ✅✅ Excellent +23.3% Low Best risk/reward 2 $CRDO ✅ Good +52.4% Medium Momentum continuation 3 $DELL ⚠️ Decent +27.6% Medium-High Momentum chasing 4 $BE ⚠️ Decent +23.5% Medium Momentum with room 5 $HNGE ❌ Poor entry +86.9% High Aggressive only
0 · Reply
MorganHoratio
MorganHoratio Jun. 23 at 6:09 PM
Your timeline will do its best to spread fear today. Your job is to find relative strength. Names standing out so far: $DAVE $OSCR $OUST $DDOG $HNGE When macro timelines aggressively broadcast fear, the ultimate mandate for smart money is identifying Relative Strength. This specific shortlist captures pristine value-growth capital insulating itself against broader market de-risking. Fintech disruption champion $DAVE (fresh off an elite earnings surprise and multi-quarter highs) and digital health pioneer $HNGE (surpassing structural breakeven inflection points) are absorbing sell-offs beautifully, maintaining pristine technical posture above historical volume nodes. $OUST, SaaS blueprint $DDOG, and insurance tech $OSCR are heavily attracting institutional inflows. Their clear right-side trend resilience indicates massive structural outperformance. Which of these anti-gravity names are you putting on top of your watchlist today?
0 · Reply
__LucidDreamer__
__LucidDreamer__ Jun. 18 at 6:23 PM
$HNGE out with a nice/quick gain. again.
0 · Reply
Pumper_Killa2
Pumper_Killa2 Jun. 18 at 6:21 PM
$HNGE Closing my short here. Thing is a beast.
0 · Reply
Pumper_Killa2
Pumper_Killa2 Jun. 15 at 5:58 PM
$HNGE Shorting here for a swing trade. I'm not seeing a 'knock out' candle that takes out 70 strongly. Will go back to 60.
0 · Reply
MorganHoratio
MorganHoratio Jun. 15 at 4:41 PM
Here are some of the most prominent themes that our team is focusing on: Healthcare: $OSCR $HNGE $UNH $JNJ $HTFL This Healthcare watchlist captures the vital rotating theme of mid-2026: smart money is spilling out of legacy defensive value into high-pricing-power digital health and clinical AI disruptors. The underlying fundamentals here are stellar. Digital MSK leader $HNGE just hiked its full-year 2026 growth outlook to a rampant 40% at its June 10 Investor Day. Meanwhile, AI coronary pioneer $HTFL raised its fiscal guidance following a blowout 41% YoY Q1 revenue jump on rapid product adoption. Concurrently, insurtech leader $OSCR is holding multi-year highs, while legacy staples like $UNH (navigating its recent FTC insulin settlement) and $JNJ reset to deep structural support. Are you sheltering in cash-cow defensive giants like $UNH, or accumulating high-growth AI health turnarounds like $HNGE and $HTFL on this necessary dip?
0 · Reply
tarded
tarded Jun. 15 at 4:12 PM
$HNGE BUY BUY BUY
0 · Reply
TheBullishTrade
TheBullishTrade Jun. 15 at 3:24 PM
$HNGE $GH $NTRA $NBIS $KOPN Every stock experiences pullbacks at some point. As a shareholder, those periods can be frustrating, especially when your thesis remains intact but the market doesn’t agree with you in the short term. However, when a stock becomes excessively oversold and the underlying fundamentals remain strong, sentiment often shifts, and the market eventually recognizes its value. Patience is often required while waiting for that disconnect between price and fundamentals to correct itself. This was back in April when these stocks are pulling back big time and just reclaimed 52 weeks high in just a little over 1 month. Crazy reversal.
0 · Reply
cokespo0n
cokespo0n Jun. 15 at 2:13 PM
$HNGE new Ath this morning. big move toward analyst upgraded price targets
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Jun. 12 at 11:45 AM
$HNGE Raised to 90 KEYB
1 · Reply
Latest News on HNGE
Hinge Health price target raised to $65 from $55 at Baird

2026-06-17T10:21:48.000Z - 7 days ago

Hinge Health price target raised to $65 from $55 at Baird


Hinge Health price target raised to $90 from $75 at KeyBanc

2026-06-12T10:35:36.000Z - 12 days ago

Hinge Health price target raised to $90 from $75 at KeyBanc


Hinge Health price target raised to $85 from $79 at Truist

2026-06-11T13:40:33.000Z - 13 days ago

Hinge Health price target raised to $85 from $79 at Truist


Hinge Health price target raised to $76 from $63 at Needham

2026-06-11T11:23:50.000Z - 13 days ago

Hinge Health price target raised to $76 from $63 at Needham


Hinge Health price target raised to $70 from $62 at Barclays

2026-06-11T09:33:33.000Z - 13 days ago

Hinge Health price target raised to $70 from $62 at Barclays


Hinge Health Transcript: Investor Day 2026

Jun 10, 2026, 2:00 PM EDT - 14 days ago

Hinge Health Transcript: Investor Day 2026


Hinge Health Press release: FY 2026

Jun 10, 2026, 2:00 PM EDT - 14 days ago

Hinge Health Press release: FY 2026


Hinge Health Slides: FY 2026

Jun 10, 2026, 2:00 PM EDT - 14 days ago

Hinge Health Slides: FY 2026


Hinge Health adds orthopedic surgery to HingeSelect

2026-06-10T13:32:22.000Z - 14 days ago

Hinge Health adds orthopedic surgery to HingeSelect


Hinge Health price target raised to $79 from $67 at Stifel

2026-06-10T10:40:35.000Z - 14 days ago

Hinge Health price target raised to $79 from $67 at Stifel


Hinge Health hosts its first Investor Day and raises guidance

Jun 9, 2026, 4:05 PM EDT - 15 days ago

Hinge Health hosts its first Investor Day and raises guidance


Hinge Health price target raised to $65 from $63 at Canaccord

2026-06-04T10:55:09.000Z - 20 days ago

Hinge Health price target raised to $65 from $63 at Canaccord


Hinge Health Transcript: AGM 2026

Jun 3, 2026, 12:00 PM EDT - 21 days ago

Hinge Health Transcript: AGM 2026


Hinge Health price target raised to $62 from $52 at Barclays

2026-05-07T10:24:04.000Z - 6 weeks ago

Hinge Health price target raised to $62 from $52 at Barclays


Hinge Health Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 7 weeks ago

Hinge Health Earnings Call Transcript: Q1 2026


Hinge Health Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 7 weeks ago

Hinge Health Earnings release: Q1 2026


Hinge Health Slides: Q1 2026

May 5, 2026, 4:30 PM EDT - 7 weeks ago

Hinge Health Slides: Q1 2026


Hinge Health Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 7 weeks ago

Hinge Health Quarterly report: Q1 2026


Hinge Health launches comprehensive Migraine Care Program

Apr 29, 2026, 10:00 AM EDT - 2 months ago

Hinge Health launches comprehensive Migraine Care Program


Hinge Health Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 2 months ago

Hinge Health Proxy statement: Proxy filing


Hinge Health Proxy statement: Proxy filing

Apr 17, 2026, 8:00 AM EDT - 2 months ago

Hinge Health Proxy statement: Proxy filing


Hinge Health appoints Tyler Sloat to its board of directors

Mar 17, 2026, 4:05 PM EDT - 3 months ago

Hinge Health appoints Tyler Sloat to its board of directors


Hinge Health Earnings Call Transcript: Q4 2025

Feb 10, 2026, 4:30 PM EST - 4 months ago

Hinge Health Earnings Call Transcript: Q4 2025


Hinge Health Annual report: Q4 2025

Feb 10, 2026, 4:30 PM EST - 4 months ago

Hinge Health Annual report: Q4 2025


Hinge Health Earnings release: Q4 2025

Feb 10, 2026, 4:30 PM EST - 4 months ago

Hinge Health Earnings release: Q4 2025


Hinge Health Slides: Q4 2025

Feb 10, 2026, 4:30 PM EST - 4 months ago

Hinge Health Slides: Q4 2025


Hinge Health Reduces MRIs and X-Rays for Back Pain by 60%

Nov 24, 2025, 11:00 AM EST - 7 months ago

Hinge Health Reduces MRIs and X-Rays for Back Pain by 60%


Hinge Health announces $250 million share repurchase program

Nov 12, 2025, 9:00 AM EST - 8 months ago

Hinge Health announces $250 million share repurchase program


Hinge Health Earnings Call Transcript: Q3 2025

Nov 4, 2025, 4:30 PM EST - 8 months ago

Hinge Health Earnings Call Transcript: Q3 2025


Hinge Health Quarterly report: Q3 2025

Nov 4, 2025, 4:30 PM EST - 8 months ago

Hinge Health Quarterly report: Q3 2025


Hinge Health Earnings release: Q3 2025

Nov 4, 2025, 4:30 PM EST - 8 months ago

Hinge Health Earnings release: Q3 2025


Hinge Health Slides: Q3 2025

Nov 4, 2025, 4:30 PM EST - 8 months ago

Hinge Health Slides: Q3 2025


Hinge Health reports third quarter 2025 financial results

Nov 4, 2025, 4:05 PM EST - 8 months ago

Hinge Health reports third quarter 2025 financial results


Hinge Health unveils new AI-powered care tools

Oct 21, 2025, 11:00 AM EDT - 8 months ago

Hinge Health unveils new AI-powered care tools


Hinge Health CEO on Q2 earnings since IPO, AI usage and growth

Aug 5, 2025, 4:53 PM EDT - 11 months ago

Hinge Health CEO on Q2 earnings since IPO, AI usage and growth


Hinge Health Earnings Call Transcript: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 11 months ago

Hinge Health Earnings Call Transcript: Q2 2025


Hinge Health Quarterly report: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 11 months ago

Hinge Health Quarterly report: Q2 2025


Hinge Health Earnings release: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 11 months ago

Hinge Health Earnings release: Q2 2025


Hinge Health Slides: Q2 2025

Aug 5, 2025, 4:30 PM EDT - 11 months ago

Hinge Health Slides: Q2 2025


Hinge Health Reports Second Quarter 2025 Financial Results

Aug 5, 2025, 4:05 PM EDT - 11 months ago

Hinge Health Reports Second Quarter 2025 Financial Results


Hinge Health Goes Public, Raising $437M for Investors

May 22, 2025, 3:19 PM EDT - 1 year ago

Hinge Health Goes Public, Raising $437M for Investors


Hinge Health raises $437.3 million in US IPO

May 21, 2025, 7:15 PM EDT - 1 year ago

Hinge Health raises $437.3 million in US IPO


Hinge Health prices IPO at $32, the top end of expected range

May 21, 2025, 6:26 PM EDT - 1 year ago

Hinge Health prices IPO at $32, the top end of expected range


Hinge Health Announces Pricing of Initial Public Offering

May 21, 2025, 6:21 PM EDT - 1 year ago

Hinge Health Announces Pricing of Initial Public Offering


Hinge Health Registration statement: Registration Filing

May 16, 2025, 8:00 AM EDT - 1 year ago

Hinge Health Registration statement: Registration Filing


Hinge Health Aims to Raise $437 Million in IPO

May 13, 2025, 1:00 PM EDT - 1 year ago

Hinge Health Aims to Raise $437 Million in IPO


Hinge Health Announces Launch of Initial Public Offering

May 13, 2025, 8:40 AM EDT - 1 year ago

Hinge Health Announces Launch of Initial Public Offering


Hinge Health Registration statement: Registration Filing

May 13, 2025, 8:00 AM EDT - 1 year ago

Hinge Health Registration statement: Registration Filing


Hinge Health targets $2.6 billion valuation in NYSE IPO

May 13, 2025, 6:46 AM EDT - 1 year ago

Hinge Health targets $2.6 billion valuation in NYSE IPO


Hinge Health Registration statement: Registration Filing

May 5, 2025, 8:00 AM EDT - 1 year ago

Hinge Health Registration statement: Registration Filing


victorgn
victorgn Jun. 24 at 7:01 PM
Rank Ticker Entry Quality Upside Risk Level Best For 1 $APP ✅✅ Excellent +23.3% Low Best risk/reward 2 $CRDO ✅ Good +52.4% Medium Momentum continuation 3 $DELL ⚠️ Decent +27.6% Medium-High Momentum chasing 4 $BE ⚠️ Decent +23.5% Medium Momentum with room 5 $HNGE ❌ Poor entry +86.9% High Aggressive only
0 · Reply
MorganHoratio
MorganHoratio Jun. 23 at 6:09 PM
Your timeline will do its best to spread fear today. Your job is to find relative strength. Names standing out so far: $DAVE $OSCR $OUST $DDOG $HNGE When macro timelines aggressively broadcast fear, the ultimate mandate for smart money is identifying Relative Strength. This specific shortlist captures pristine value-growth capital insulating itself against broader market de-risking. Fintech disruption champion $DAVE (fresh off an elite earnings surprise and multi-quarter highs) and digital health pioneer $HNGE (surpassing structural breakeven inflection points) are absorbing sell-offs beautifully, maintaining pristine technical posture above historical volume nodes. $OUST, SaaS blueprint $DDOG, and insurance tech $OSCR are heavily attracting institutional inflows. Their clear right-side trend resilience indicates massive structural outperformance. Which of these anti-gravity names are you putting on top of your watchlist today?
0 · Reply
__LucidDreamer__
__LucidDreamer__ Jun. 18 at 6:23 PM
$HNGE out with a nice/quick gain. again.
0 · Reply
Pumper_Killa2
Pumper_Killa2 Jun. 18 at 6:21 PM
$HNGE Closing my short here. Thing is a beast.
0 · Reply
Pumper_Killa2
Pumper_Killa2 Jun. 15 at 5:58 PM
$HNGE Shorting here for a swing trade. I'm not seeing a 'knock out' candle that takes out 70 strongly. Will go back to 60.
0 · Reply
MorganHoratio
MorganHoratio Jun. 15 at 4:41 PM
Here are some of the most prominent themes that our team is focusing on: Healthcare: $OSCR $HNGE $UNH $JNJ $HTFL This Healthcare watchlist captures the vital rotating theme of mid-2026: smart money is spilling out of legacy defensive value into high-pricing-power digital health and clinical AI disruptors. The underlying fundamentals here are stellar. Digital MSK leader $HNGE just hiked its full-year 2026 growth outlook to a rampant 40% at its June 10 Investor Day. Meanwhile, AI coronary pioneer $HTFL raised its fiscal guidance following a blowout 41% YoY Q1 revenue jump on rapid product adoption. Concurrently, insurtech leader $OSCR is holding multi-year highs, while legacy staples like $UNH (navigating its recent FTC insulin settlement) and $JNJ reset to deep structural support. Are you sheltering in cash-cow defensive giants like $UNH, or accumulating high-growth AI health turnarounds like $HNGE and $HTFL on this necessary dip?
0 · Reply
tarded
tarded Jun. 15 at 4:12 PM
$HNGE BUY BUY BUY
0 · Reply
TheBullishTrade
TheBullishTrade Jun. 15 at 3:24 PM
$HNGE $GH $NTRA $NBIS $KOPN Every stock experiences pullbacks at some point. As a shareholder, those periods can be frustrating, especially when your thesis remains intact but the market doesn’t agree with you in the short term. However, when a stock becomes excessively oversold and the underlying fundamentals remain strong, sentiment often shifts, and the market eventually recognizes its value. Patience is often required while waiting for that disconnect between price and fundamentals to correct itself. This was back in April when these stocks are pulling back big time and just reclaimed 52 weeks high in just a little over 1 month. Crazy reversal.
0 · Reply
cokespo0n
cokespo0n Jun. 15 at 2:13 PM
$HNGE new Ath this morning. big move toward analyst upgraded price targets
0 · Reply
NeverFadeTheOracle
NeverFadeTheOracle Jun. 12 at 11:45 AM
$HNGE Raised to 90 KEYB
1 · Reply
JFDI
JFDI Jun. 11 at 6:34 PM
$HNGE big B/O
0 · Reply
Pumper_Killa2
Pumper_Killa2 Jun. 11 at 6:16 PM
$HNGE Killa.
0 · Reply
__LucidDreamer__
__LucidDreamer__ Jun. 10 at 7:39 PM
$HNGE back in
0 · Reply
MarketMaestro1
MarketMaestro1 Jun. 10 at 7:36 PM
Relative strength in healthcare and defensive sectors: $UNH $CVS $OSCR $VSH $HNGE These names reflect more stable cash flow profiles in uncertain markets. Not exciting. But often resilient when volatility increases.
0 · Reply
Pumper_Killa2
Pumper_Killa2 Jun. 10 at 7:07 PM
$HNGE Covering my daily short here for a 6K bag. This is a massive bullish play long term. Killa.
0 · Reply
Pumper_Killa2
Pumper_Killa2 Jun. 10 at 3:19 PM
$HNGE Shorting here. This will go negative. Day trade.
0 · Reply
theflynews
theflynews Jun. 10 at 1:25 PM
Pre-Market Fly By for Wednesday, June 10th: Breaking Stock Market News $SMCI $CHWY $CBRL $HNGE $DNTH
0 · Reply
theflynews
theflynews Jun. 10 at 1:10 PM
Morning Movers: Dianthus plummets after peer Sanofi halts trial - $HNGE - https://thefly.com/HNGE
0 · Reply
DonCorleone77
DonCorleone77 Jun. 10 at 1:10 PM
$YB $CBRL $CNM $CAVA $HNGE PRE-MARKET MOVERS: Currently Higher After Earnings: - Yuanbao (YB) up 16.8% - Cracker Barrel (CBRL) up 15.6% - Lakeland Industries (LAKE) up 9.4% - Core & Main (CNM) up 1.0% Currently Also Higher: - Cava Group (CAVA) up 2.3% after UBS upgraded the stock to Buy with a price target of $90, up from $85 - Hinge Health (HNGE) up 4.6% after raising its Q2 and FY26 revenue outlook at its inaugural investor day Currently Lower After Earnngs: - Chewy (CHWY) down 4.7% - J.Jill (JILL) down 0.3% Currently Also Lower: - Dianthus (DNTH) down 19.4% after peer Sanofi (SNY) announced that its riliprubart Phase 3 study in patients with chronic inflammatory demyelinating polyneuropathy will be stopped - Super Micro (SMCI) down 12.2% after announcing a series of concurrent equity and equity-linked financing transactions totaling $7B, in expected aggregate amount as part of its plan to fund the purchase of components to satisfy the AI orders that the company has received in recent weeks for its advanced AI servers - Nike (NKE) down 1.3% after RBC Capital downgraded shares to Sector Perform with a price target of $50, down from $70
0 · Reply
OpenOutcrier
OpenOutcrier Jun. 10 at 12:03 PM
$HNGE (+3.9% pre) Hinge Health stock rises after raising 2026 revenue guidance https://ooc.bz/l/104714
0 · Reply
AXLFI_HQ
AXLFI_HQ Jun. 9 at 11:22 PM
$HNGE Biotechnology and pharmaceutical companies face divergent outcomes based on clinical trial results and regulatory pathway clarity, with failed trials forcing restructuring while successful programs advance. Learn more: https://axlfi.com/themes/341
0 · Reply
itsfloridaking
itsfloridaking Jun. 9 at 2:29 PM
$HNGE new highs incoming!!!
0 · Reply